Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Drove Abacusglobal Abxl Stock Higher This Week Price At 25.43 Down 0.13 20260402 Is Health Catalyst Hcat Stock A Future Winner Price At 0.98 Down 2.48 20260410 Is Southland Holdings Slnd Stock Near Resistance Price At 1.32 Down 0.30 20260406 Is Compass Cmps Stock Undervalued Now Price At 5.68 Down 0.70 20260409 Is Eaton Eot Stock Tied To Economic Cycles Price At 17.13 Up 0.41 20260409 Nike NKE Stock Why Moaty Business 072 20260418 WidePoint Corporation WYY Stock LongTerm View Eye on Rally 20260415 HURA TuHURA Biosciences Inc posts 282 percent negative Q4 2025 EPS surprise with shares falling 135 percent today The investment case for Mirum Pharmaceuticals MIRM in simple terms 411 20260508 Norfolk Southern Corporation NSC Q1 2026 Earnings Preview Balanced RiskReward Ahead of Upcoming Release DTG DTE Energy reports 72 percent Q4 2025 EPS beat shares edge slightly lower in muted trading HL Hecla posts 20 percent Q4 2025 EPS beat shares rise 481 percent on upbeat investor sentiment BGM Group BGM Stock Investment Outlook Technical Weakness 20260422 Comcast Corporation CMCSA Stock End of Year Eye on Rally 20260420 AEON Bio AEON posts sharply wider than expected Q4 2025 loss shares drop 358 amid investor disappointment SEER Seer reports narrower than expected Q4 2025 loss shares climb 372 percent on positive investor sentiment MAIN Main notches slight share gain after Q4 2025 earnings top consensus EPS estimates by 43 percent TBCH Turtle shares rise 249 percent despite Q4 2025 earnings missing analyst expectations by 237 percent BST Blk SciTech reports quarterly results as AIdriven tech investments drive portfolio performance dividend unchanged Canada to Review Amazon Cloud Contracts Following Quebec Warehouse Closures As Airlines Face Jet Fuel Shortages Travelers Shift to Trains and Staycations Ryanair CEO Voya Asia IAE Stock Down 202 Support Test at 782 20260515 Cerebras IPO Surges as AI Chip Demand Propels Nvidia Competitor into Public Markets After USChina Summit Iran Digs In Heels Over Hormuz Raising Oil Supply Concerns Abacus Global ABX Stock Steady at 913 Support at 867 20260515 Elon Musk Loses Court Battle Against OpenAI Legal Setback for AI Governance Erayak RAYA Surges 861 Nearing 384 Resistance 20260515 American Consumer Pessimism Persists Economists Question When Sentiment May Recover Century Casinos CNTY Q1 2026 Earnings Beat Revenue NA EPS 058 Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Potential Market Recovery in Coming Quarters Whats Next for Parsons Corporation PSN at 5079 20260520 Tourism Finance Corporation of India Gains Attention as Fund Linked to Rakesh Jhunjhunwala Acquires Stake Consumer Sentiment Plunges to Record Low in May Amid USIran Tensions and Oil Price Surge Intuit Earnings May Validate or Challenge Morgan Stanleys Stock Forecast Gold Holds Above 4500 Support as USIran Tensions Intensify Eli Lilly Reports Strong Q1 2026 Earnings Raises FullYear Guidance on Mounjaro Momentum and GLP1 Demand PRAX Q1 2026 Earnings EPS Beat Amid Continued RD Focus WBD Q1 2026 Earnings NarrowerthanExpected Loss Amid Strategic Restructuring AMREP Corporation Q1 2026 Earnings Slight EPS Beat Drives Modest Stock Uptick Okeanis Eco Tankers Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions FTI Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher Marine Petroleum Trust MARPS Edges Lower Amid Light Trading Axalta Coating Systems Edges Higher as Shares Test Key Resistance Zone Genesis Energy GEL Slips 134 as Energy Sector Headwinds Persist StepStone Group Inc STEP Slips 2 as Broader Market Headwinds Test Key Support Viewbix VBIX Stock Trading Guide 783 20260420 CRGY Crescent Q4 2025 results beat forecasts 41 percent EPS surprise and 22 percent revenue growth lift shares MDU MDU Stock Key Resistance Marginal Gain 20260420 BCG Binah Capital posts 107 percent year over year Q1 2026 revenue growth shares edge higher TELO Telomir Pharmaceuticals gains slightly even as Q4 2025 EPS lands far below analyst consensus estimates